CUV 1.61% $14.68 clinuvel pharmaceuticals limited

Ann: Media release - First stroke patient with afamelanotide, page-18

  1. 7,705 Posts.
    lightbulb Created with Sketch. 2797
    ROTFL. The FDA says Phase IV trial are required. Drugs are routinely withdrawn from the market because they cause adverse effects when widely prescribed,
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.